Guanze Medical to Review H1 2026 Interim Results and Potential Dividend on 31 August

Bulletin Express

Aug 17

Guanze Medical Information Industry (Holding) Co., Ltd. has scheduled a board meeting for Monday, 31 August 2026. The agenda includes three key items:

1. Assessing and, if appropriate, approving the unaudited consolidated interim results for the six-month period ended 30 June 2026.

2. Considering the declaration and payment of an interim dividend, subject to board approval.

3. Addressing any other routine business matters.

The notice, dated 17 August 2026, was signed by Chairwoman Jiang Zeman on behalf of the board. The company’s current board comprises three executive directors—Jiang Zeman, Qin Jingying and Meng Xianzhen—and three independent non-executive directors—Dr. Zhao Bin, Dr. Chang Shiwang and Dr. Wong Man Hin Raymond.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1179225137"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1179225137\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1179225137?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-17 17:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1179225137","market":"us","top_or_hot":-1,"title":"Guanze Medical to Review H1 2026 Interim Results and Potential Dividend on 31 August","media":"Bulletin Express","content":"<p>Guanze Medical Information Industry (Holding) Co., Ltd. has scheduled a board meeting for Monday, 31 August 2026. The agenda includes three key items:</p>\n<p>1. Assessing and, if appropriate, approving the unaudited consolidated interim results for the six-month period ended 30 June 2026.</p>\n<p>2. Considering the declaration and payment of an interim dividend, subject to board approval.</p>\n<p>3. Addressing any other routine business matters.</p>\n<p>The notice, dated 17 August 2026, was signed by Chairwoman Jiang Zeman on behalf of the board. The company’s current board comprises three executive directors—Jiang Zeman, Qin Jingying and Meng Xianzhen—and three independent non-executive directors—Dr. Zhao Bin, Dr. Chang Shiwang and Dr. Wong Man Hin Raymond.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Guanze Medical to Review H1 2026 Interim Results and Potential Dividend on 31 August</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGuanze Medical to Review H1 2026 Interim Results and Potential Dividend on 31 August\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-17 17:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Guanze Medical Information Industry (Holding) Co., Ltd. has scheduled a board meeting for Monday, 31 August 2026. The agenda includes three key items:</p>\n<p>1. Assessing and, if appropriate, approving the unaudited consolidated interim results for the six-month period ended 30 June 2026.</p>\n<p>2. Considering the declaration and payment of an interim dividend, subject to board approval.</p>\n<p>3. Addressing any other routine business matters.</p>\n<p>The notice, dated 17 August 2026, was signed by Chairwoman Jiang Zeman on behalf of the board. The company’s current board comprises three executive directors—Jiang Zeman, Qin Jingying and Meng Xianzhen—and three independent non-executive directors—Dr. Zhao Bin, Dr. Chang Shiwang and Dr. Wong Man Hin Raymond.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02427","symbol_name":"GUANZE MEDICAL","start_time":0,"source_url":"","article_id":"1179225137","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1179225137","pubTimestamp":1786957628,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Guanze Medical Information Industry (Holding) Co., Ltd. has scheduled a board meeting for Monday, 31 August 2026. The agenda includes three key items: 1. Assessing and, if appropriate, approving the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02427":"GUANZE MEDICAL"},"translate_title":"冠泽医疗将于8月31日审阅2026年上半年中期业绩及潜在股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02427":1},"content_text":"Guanze Medical Information Industry (Holding) Co., Ltd. has scheduled a board meeting for Monday, 31 August 2026. The agenda includes three key items:\n1. Assessing and, if appropriate, approving the unaudited consolidated interim results for the six-month period ended 30 June 2026.\n2. Considering the declaration and payment of an interim dividend, subject to board approval.\n3. Addressing any other routine business matters.\nThe notice, dated 17 August 2026, was signed by Chairwoman Jiang Zeman on behalf of the board. The company’s current board comprises three executive directors—Jiang Zeman, Qin Jingying and Meng Xianzhen—and three independent non-executive directors—Dr. Zhao Bin, Dr. Chang Shiwang and Dr. Wong Man Hin Raymond.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}